BACKGROUND: Tools are needed to predict which individuals with diabetes will develop kidney disease and its complications. STUDY DESIGN: An observational analysis of a randomized controlled trial. SETTING & PARTICIPANTS: The ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation) Study followed up 11,140 participants with type 2 diabetes for 5 years. PREDICTOR: Readily available baseline demographic and clinical variables. OUTCOMES: (1) Major kidney-related events (doubling of serum creatinine to >/=2.26 mg/dL [>/=200 mumol/L], renal replacement therapy, or renal death) in all participants, and (2) new-onset albuminuria in participants with baseline normoalbuminuria. MEASUREMENTS: Cox proportional hazard regression models predicting the outcomes were used to generate risk scores. Discrimination of the risk prediction models was compared with that of models based on estimated glomerular filtration rate (eGFR) alone, urinary albumin-creatinine ratio (ACR) alone, and their combination. RESULTS: Risk scores for major kidney-related events and new-onset albuminuria were derived from 7- and 8-variable models, respectively. Baseline eGFR and ACR were dominant although models based on the 2 factors, alone or combined, had less discrimination (P < 0.05) than the risk prediction models containing additional variables (risk prediction model C statistics of 0.847 [95% CI, 0.815-0.880] for major kidney-related events, and 0.647 [95% CI, 0.637-0.658] for new-onset albuminuria). Novel risk factors for new-onset albuminuria included Asian ethnicity and greater waist circumference, and for major kidney-related events, less education. The risk prediction models had acceptable calibration for both outcomes (modified Hosmer-Lemeshow test, P = 0.9 and P = 0.06, respectively). LIMITATIONS: The follow-up period was limited to 5 years. Results are applicable to people with type 2 diabetes at risk of vascular disease. CONCLUSIONS: Risk scores have been developed for early and late events in diabetic nephropathy. Although eGFR and urinary ACR are important components of the prediction models, the extra variables considered add significantly to discrimination and, in the case of new-onset albuminuria, are required to achieve satisfactory calibration.
AD - The George Institute for Global Health, Sydney, Australia; Concord Repatriation General Hospital, Sydney, Australia. AN - 22694950 BT - American Journal of Kidney Diseases C2 - 22694950 ET - 2012/06/15 LA - Eng M1 - 5 N1 - ADVANCE Collaborative GroupAmerican journal of kidney diseases : the official journal of the National Kidney FoundationAm J Kidney Dis. 2012 Jun 11. N2 -BACKGROUND: Tools are needed to predict which individuals with diabetes will develop kidney disease and its complications. STUDY DESIGN: An observational analysis of a randomized controlled trial. SETTING & PARTICIPANTS: The ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation) Study followed up 11,140 participants with type 2 diabetes for 5 years. PREDICTOR: Readily available baseline demographic and clinical variables. OUTCOMES: (1) Major kidney-related events (doubling of serum creatinine to >/=2.26 mg/dL [>/=200 mumol/L], renal replacement therapy, or renal death) in all participants, and (2) new-onset albuminuria in participants with baseline normoalbuminuria. MEASUREMENTS: Cox proportional hazard regression models predicting the outcomes were used to generate risk scores. Discrimination of the risk prediction models was compared with that of models based on estimated glomerular filtration rate (eGFR) alone, urinary albumin-creatinine ratio (ACR) alone, and their combination. RESULTS: Risk scores for major kidney-related events and new-onset albuminuria were derived from 7- and 8-variable models, respectively. Baseline eGFR and ACR were dominant although models based on the 2 factors, alone or combined, had less discrimination (P < 0.05) than the risk prediction models containing additional variables (risk prediction model C statistics of 0.847 [95% CI, 0.815-0.880] for major kidney-related events, and 0.647 [95% CI, 0.637-0.658] for new-onset albuminuria). Novel risk factors for new-onset albuminuria included Asian ethnicity and greater waist circumference, and for major kidney-related events, less education. The risk prediction models had acceptable calibration for both outcomes (modified Hosmer-Lemeshow test, P = 0.9 and P = 0.06, respectively). LIMITATIONS: The follow-up period was limited to 5 years. Results are applicable to people with type 2 diabetes at risk of vascular disease. CONCLUSIONS: Risk scores have been developed for early and late events in diabetic nephropathy. Although eGFR and urinary ACR are important components of the prediction models, the extra variables considered add significantly to discrimination and, in the case of new-onset albuminuria, are required to achieve satisfactory calibration.
PY - 2012 RN - (IF: 5.4] SE - 770 SN - 1523-6838 (Electronic)0272-6386 (Linking) EP - 9 T2 - American Journal of Kidney Diseases TI - Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes VL - 60 ER -